PDCD1 and neoplasm: CD30 protein expression and the programmed cell death protein-1 receptor (PD-1) and ligands (PD-L1/PD-L2) immune modulatory pathway have proven to be relevant for tumor development and survival and represent key targets for novel treatment strategies [9,10].